CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer

NESS ZIONA, Israel, April 12, 2018 -- (Healthcare Sales & Marketing Network) -- CollPlant (NASDAQ: CLGN) (TASE: CLGN), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products (recombinant hum... Regenerative Medicine, Personnel CollPlant, rhCollagen, Vergenix, VergenixSTR
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news